Major companies had faced mounting pressure to stop denying or stalling authorization of coverage for treatments and prescriptions.
Related Posts
Sarah Palin’s Libel Trial Against The New York Times Begins
In opening statements, lawyers for Sarah Palin and The Times each presented arguments on whether the editorial board had published a statement knowing it was […]
Can Quake-Prone Japan Ever Embrace Nuclear Energy Again?
The government, its makeup in flux after the ruling party lost seats this week, will soon need to make decisions that will shape Japan’s future […]
‘Trump Bump’ in Stocks Fades Amid Rising Economic Anxiety
Stocks soared after President Trump’s win. But that rally largely reversed in February. On Friday, the S&P 500 was on track for its worst week […]